lunatusin

General Information


DRACP ID  DRACP00148

Peptide Name   lunatusin

Sequence  KTCENLADTFRGPCFATSNC

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Phaseolus lunatus

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=5.71 µM MTT assay 4 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00148

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C90H140N26O31S3

Absent amino acids  HIMQVWY

Common amino acids  CT

Mass  251752

Pl  6.15

Basic residues  2

Acidic residues  2

Hydrophobic residues  5

Net charge  0

Boman Index  -4111

Hydrophobicity  -34

Aliphatic Index  29.5

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  6.58

Polar residues  10

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16269344

Title  Lunatusin, a trypsin-stable antimicrobial peptide from lima beans (Phaseolus lunatus L.)

Doi 10.1016/j.peptides.2005.03.004

Year  2005

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.